폐경 증상을 호소하는 폐경 이행기 여성에서 갑상선 감별 진단의 필요성 = The Necessity of Thyroid Function Test of Perimenopausal Women with Menopausal Symptoms

다국어 초록 (Multilingual Abstract)

Objectives: Hormone therapy is generally chosen to treat women who are experiencing menopausal symptoms. Knowing the overlapping symptoms between menopause and thyroid diseases as well as their increasing trend, it is crucial to differentially diagnose among the two types of diseases. The study is focused on the thyroid function test (TFT) and its significance. It also reflects those who are in the menopausal transition state, suffering from premenopausal symptoms, and therefore, want to be treated with hormone therapy. Methods: Endocrinologic diagnosis for menopause was performed in 139 patients who complained of menopausal symptoms and irregular menstruation within the past year and hence, visited the Department of Obstetrics and Gynecology, Kyung Hee University Hospital in order to obtain consultation from January 2007 to March 2011. We made observations using the retrograde method. Among these women, 43 patients tested for TFT for their atypical menopausal symptoms. Results: Among the 43 patients who tested for TFT, 10 patients showed abnormal TFT and 3 patients who did not take TFT at our department were found to have the thyroid disease later by other clinics. Conclusion: In order to differentiate thyroid disease, practical guidelines should be prepared for the management of women with menopausal transition. (J Korean Soc Menopause 2012;18:174-179)

참고문헌 (Reference)

1 Birkhauser MH, "Updated practical recommendations for hormone replacement therapy in the peri- and postmenopause" 11 : 108-123, 2008

2 Sowers M, "Thyroid stimulating hormone (TSH) concentrations and menopausal status in women at the mid-life: SWAN" 58 : 340-347, 2003

3 Schindler AE, "Thyroid function and postmenopause" 17 : 79-85, 2003

4 Pearce EN, "Thyroid dysfunction in perimenopausal and postmenopausal women" 13 : 8-13, 2007

5 Mitrou P, "Thyroid disease in older people" 70 : 5-9, 2011

6 McKinlay SM, "The normal menopause transition" 61 : 4-16, 2008

7 Practice Committee of American Society for Reproductive Medicine., "The menopausal transition" 90 : S61-S65, 2008

8 Bruce D, "Symptoms of the menopause" 23 : 25-32, 2009

9 World Health Organization, "Research on the menopause in the 1990s. Report of a WHO Scientific Group" 866 : 1-107, 1996

10 Shifren JL, "Menopause, In Berek & Novak’s gynecology. 14th ed" Lippincott Williams & Wilkins 1323-1340, 2007

11 Arafah BM, "Increased need for thyroxine in women with hypothyroidism during estrogen therapy" 344 : 1743-1749, 2001

12 Rymer J, "Extracts from “Clinical evidence”: menopausal symptoms" 321 : 1516-1519, 2000

13 Soules MR, "Executive summary: Stages of Reproductive Aging Workshop (STRAW)" 76 : 874-878, 2001

14 Klein NA, "Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles" 81 : 2742-2745, 1996

15 Speroff L, "Clinical gynecologic endocrinology and infertility. 7th ed" Lippincott Williams & Wilkins 2005

16 Badawy A, "Can thyroid dysfunction explicate severe menopausal symptoms?" 27 : 503-505, 2007

17 Faddy MJ, "Accelerated disappearance of ovarian follicles in midlife : implications for forecasting menopause" 7 : 1342-1346, 1992